Close

Amgen (AMGN) Announces Publication of Positive BLINCYTO Phase 1/2 Single-Arm Trial in ALL; Says 39% Achieved Complete Remission

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/25/2024

1. META
2. CMG
3. LRCX
4. IBM
5. HCP
6. SPY
7. BSX
8. PI
9. CNMD
10. NOW


Go back to Amgen (AMGN) Announces Publication of Positive BLINCYTO Phase 1/2 Single-Arm Trial in ALL; Says 39% Achieved Complete Remission
Amgen Inc (NASDAQ: AMGN) Delayed: 270.93 -2.08 (0.76%)
Previous Close $273.01    52 Week High $176.85 
Open $273.45    52 Week Low $133.64 
Day High $274.35    P/E 40.80 
Day Low $270.87    EPS $6.64 
Volume 138,468